Abiopharma

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Aeropay Announces Integration with Jack Henry to Strengthen Instant Pay by Bank Infrastructure

Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology

Clinical trial NCT07291076: enrollment: 129 → 198 participants.

Clinical trial NCT02856893 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-12-01 → 2025-08-12

Clinical trial NCT07166094 updates: 1. completion date: 2029-02-01 → 2029-11-01 2. primary completion date: 2028-11-01 → 2029-08-01 3. enrollment: 544 → 660 participants

Clinical trial NCT05663866: completion date: 2026-07-30 → 2027-03-31.

Clinical trial NCT04346238 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2021-09-30 → 2024-12-01 3. primary completion date: 2021-03-30 → 2024-03-30 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03998254: completion date: 2028-03-31 → 2029-11-30.

Clinical trial NCT05759013 updates: 1. status: ENROLLING_BY_INVITATION → COMPLETED 2. completion date: 2026-03-31 → 2026-05-01 3. primary completion date: 2025-12-31 → 2026-02-15 4. enrollment: 272 → 250 participants 5. enrollment type: ESTIMATED → ACTUAL